This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanson, J. L. Articles by Baldwin, A. S. Search for Related Content PubMed PubMed Citation Articles by Hanson, J. L. Articles by Baldwin, A. S.

The Nuclear Factor B Subunits RelA/p65 and c-Rel Potentiate but Are Not Required for Ras-Induced Cellular Transformation

¹ Lineberger Comprehensive Cancer Center, ² Curriculum in Genetics and Molecular Biology, and ³ Department of Biology, University of North Carolina, Chapel Hill, North Carolina

Extensive data indicate that oncoproteins, such as oncogenic H-Ras, initiate signal transduction cascades that ultimately lead to the activation of specific transcription factors. We and others have previously demonstrated that Ras activates the inherent transcriptional activation function of the transcription factor nuclear factor B (NF-B). Supportive of the importance of NF-B in transformation, Ras-induced cellular transformation can be suppressed by expression of IB, an inhibitor of NF-B, or by dominant-negative forms of the upstream activator IB kinase (IKK). However, conclusive evidence for a requirement for NF-B subunits in oncogenic transformation has not been reported. Furthermore, there is little understanding of the gene targets controlled by NF-B that might support oncogenic conversion. The data presented here demonstrate that, although both p65 and c-Rel enhance the frequency of Ras-induced cellular transformation, these NF-B subunits are not essential for Ras to transform spontaneously immortalized murine fibroblasts. Microarray analysis identified a set of genes induced by Ras that is dependent on NF-B for their expression and that likely play contributory roles in promoting Ras-induced oncogenic transformation.

This article has been cited by other articles:

				J. Yang, W.-H. Pan, G. A. Clawson, and A. Richmond Systemic Targeting Inhibitor of {kappa}B Kinase Inhibits Melanoma Tumor Growth Cancer Res., April 1, 2007; 67(7): 3127 - 3134. [Abstract] [Full Text] [PDF]

				E. J. Faivre and C. A. Lange Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells Mol. Cell. Biol., January 15, 2007; 27(2): 466 - 480. [Abstract] [Full Text] [PDF]

				K. A. Park, H. S. Byun, M. Won, K.-J. Yang, S. Shin, L. Piao, J. M. Kim, W.-H. Yoon, E. Junn, J. Park, et al. Sustained activation of protein kinase C downregulates nuclear factor-{kappa}B signaling by dissociation of IKK-{gamma} and Hsp90 complex in human colonic epithelial cells Carcinogenesis, January 1, 2007; 28(1): 71 - 80. [Abstract] [Full Text] [PDF]

				A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Dev., May 15, 2006; 20(10): 1218 - 1249. [Abstract] [Full Text] [PDF]